126 related articles for article (PubMed ID: 24427839)
1. Drospirenone: more cases of thrombosis than with levonorgestrel.
Prescrire Int; 2013 Nov; 22(143):267. PubMed ID: 24427839
[TBL] [Abstract][Full Text] [Related]
2. Drospirenone: high risk of venous thrombosis.
Prescrire Int; 2011 Feb; 20(113):43-5. PubMed ID: 21488592
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic risk of contraceptive transdermal patches and the contraceptive vaginal ring.
Prescrire Int; 2013 Nov; 22(143):266, 268-9. PubMed ID: 24427838
[TBL] [Abstract][Full Text] [Related]
4. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Plu-Bureau G; Sabbagh E; Hugon-Rodin J
Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
[TBL] [Abstract][Full Text] [Related]
5. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data.
Jick SS; Hernandez RK
BMJ; 2011 Apr; 342():d2151. PubMed ID: 21511805
[TBL] [Abstract][Full Text] [Related]
6. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
Seeger JD; Loughlin J; Eng PM; Clifford CR; Cutone J; Walker AM
Obstet Gynecol; 2007 Sep; 110(3):587-93. PubMed ID: 17766604
[TBL] [Abstract][Full Text] [Related]
7. Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women.
Salem JE; Dureau P; Bachelot A; Germain M; Voiriot P; Lebourgeois B; Trégouët DA; Hulot JS; Funck-Brentano C
JAMA Cardiol; 2018 Sep; 3(9):877-882. PubMed ID: 30073300
[TBL] [Abstract][Full Text] [Related]
8. Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study.
Larivée N; Suissa S; Eberg M; Joseph L; Eisenberg MJ; Abenhaim HA; Filion KB
BJOG; 2017 Oct; 124(11):1672-1679. PubMed ID: 27704723
[TBL] [Abstract][Full Text] [Related]
9. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review.
Wu CQ; Grandi SM; Filion KB; Abenhaim HA; Joseph L; Eisenberg MJ
BJOG; 2013 Jun; 120(7):801-10. PubMed ID: 23530659
[TBL] [Abstract][Full Text] [Related]
10. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.
Parkin L; Sharples K; Hernandez RK; Jick SS
BMJ; 2011 Apr; 342():d2139. PubMed ID: 21511804
[TBL] [Abstract][Full Text] [Related]
11. [Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives].
Botzenhardt S; Toni I; Rascher W; Neubert A
Klin Padiatr; 2013 Sep; 225(5):268-76. PubMed ID: 23979828
[TBL] [Abstract][Full Text] [Related]
12. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
Larivée N; Suissa S; Coulombe J; Tagalakis V; Filion KB
Drug Saf; 2017 Jul; 40(7):583-596. PubMed ID: 28382493
[TBL] [Abstract][Full Text] [Related]
13. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
Jick SS; Jick H
Contraception; 2006 Oct; 74(4):290-2. PubMed ID: 16982227
[TBL] [Abstract][Full Text] [Related]
14. Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study.
Gronich N; Lavi I; Rennert G
CMAJ; 2011 Dec; 183(18):E1319-25. PubMed ID: 22065352
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N; Smith KP
Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
[TBL] [Abstract][Full Text] [Related]
16. Irritable bowel syndrome and drospirenone-containing oral contraceptives; a comparative-safety study.
Bird ST; Liu W; Brophy JM; Bressler B; Delaney JA; Etminan M
Curr Drug Saf; 2012 Feb; 7(1):8-15. PubMed ID: 22663950
[TBL] [Abstract][Full Text] [Related]
17. Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
Lindberg M; Foldemo A; Josefsson A; Wiréhn AB
Eur J Contracept Reprod Health Care; 2012 Apr; 17(2):106-18. PubMed ID: 22385398
[TBL] [Abstract][Full Text] [Related]
18. Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.
Heinemann K; Heinemann LA
J Fam Plann Reprod Health Care; 2011 Jul; 37(3):132-5. PubMed ID: 21659330
[No Abstract] [Full Text] [Related]
19. Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone.
Blode H; Klipping C; Richard F; Trummer D; Rohde B; Diefenbach K
Contraception; 2012 Feb; 85(2):177-84. PubMed ID: 22067789
[TBL] [Abstract][Full Text] [Related]
20. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
Oelkers WH
Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
